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Abstract: In recent years, a significant increase in the frequency of disorders caused by air pollutants 
has been observed. Here we asked whether transition metal-containing particulate m atter (TMCPM), 
a com ponent of air pollution, has an  effect on the activity of hum an  CD4+ T cell subsets (Th1, Th2, 
Th17, and  Treg). Peripheral blood m ononuclear cells (PBMC) from  healthy donors w ere cultured 
w ith or w ithout NIST (SRM 1648a—standard urban particulate m atter purchased from the National 
Institute for S tandards and  Technology) and  LAP (SRM 1648a particulate m atter treated w ith in  
120 m in w ith cold oxygen plasma) preparations of TMCPM, differing in organic com pounds content. 
Data show  that TMCPM treatm ent increased the level of CD4+ cells positive for IFN-y and IL-17A, 
specific for Th1 and Th17 cells, respectively. Moreover, a substantial decrease in frequency of Foxp3 
positive CD4+ cells w as observed in parallel. This effect w as m ore pronounced for NIST particles, 
containing more organic com ponents, including endotoxin (LPS - lipopolysaccharide) and required 
the presence of monocytes. Inactivation of LPS by treatm ent of TMCPM w ith polym yxin B reduced 
the inflammatory response of monocytes and Th subsets bu t did not abolish this activity, suggesting 
a role of their inorganic components. In conclusion, treatm ent of hum an PBMC with TMCPM skews 
the balance of Th1/Th2 and Treg/Th17 cells, promoting polarization of CD4+ T cells into Th1 and Th17 
subsets. This phenom enon requires activation of monocytes and depends on the organic and inorganic 
fractions, including endotoxin content in TMCPM, as significantly higher inflam m atory response 
was observed for the NIST com paring to LAP. This observation m ay shed a new  light on the role of 
TMCPM in developm ent and exacerbation of allergies, inflammatory, and autoim m une disorders.
Keywords: transition m etal containing particulate m atter; air pollution; CD4+ T cells; m onocytes; 
cytokines; endotoxin
1. Introduction
In recent years, an  increase in  air pollution has seriously im pacted hum an 's  health  [1,2] . It has 
been accepted that air pollutants, specifically respirable particulate m atter (PM), in association w ith  
genetic predispositions, environm ental, and  epigenetic factors prom ote initiation of inflam m atory 
reactions and developm ent of allergy, inflammatory or autoim mune disorders [3- 7]. Furthermore, the 
exposure to PM is associated w ith  increased risk of pu lm onary  and  cardiovascular disease-related 
m orbidity, and  m ortality [8- 11]. TMCPM (transition m etal containing particulate m atter) consists
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of the fine, ultrafine, and  nanoparticles containing m etals, such as iron (Fe), zinc (Zn), copper (Cu), 
chromium (Cr), nickel (Ni), manganese (Mn), lead (Pb), and cadmium  (Cd) [12- 14]. Although transition 
metals are required cofactors for m any proteins that are critical for life, inhaled TMCPM can deposit 
in different com partm ents in  the respiratory tract and  interact w ith  epithelial and  resident im m une 
cells. Usually, they reach the lower respiratory tract w here they are m ainly phagocytosed by alveolar 
macrophages [15]. Smaller PM can penetrate the lower respiratory tract more efficiently and therefore 
are m ore harm ful to hum an 's health . P art of them  can also translocate from the lung  to the blood 
stream and interact w ith circulating leukocytes [16], including monocytes, which play a crucial role in 
the early phases of the immune response, phagocytosing foreign material, presenting antigens to CD4+ 
T cells and inducing antigen-specific - adaptive im m une response [17].
The hum an immune system is a sensitive target for air pollution and the optimal balance between 
activation of different cells, including Th cell subsets (Th1/Th2 and  Th17/Treg) is a key elem ent 
responsible for its homeostatic maintenance. Dysregulation of the Th1/Th2 ratio leads to excessive Th1 
or Th2 cell activation, resulting in the developm ent of inflam m atory or au toim m une diseases often 
associated w ith accumulation of Th1 cells or the induction of allergic diseases due to the accumulation 
of Th2 cells, respectively. On the other hand, an elevated level of Th17 cells and peripheral Th17/Treg 
imbalance is associated w ith the developm ent of autoim m une diseases and may also contribute to the 
pathogenesis of classically recognized Th2-mediated allergic disorders [18]. Although, the effect of the 
im mune cell exposure to PM has been well docum ented in m any animal models [19,20], the influence 
of TMCPM on hum an CD4+ T cells has been poorly defined. In this study, we investigated the effect of 
TMCPM on the activity of peripheral blood CD4+ T cell subsets (Th), determ ined by the expression of 
intracellular proteins, nam ely IFN-y, IL-4, IL-17A, and  Foxp3, (markers for Th1, Th2, Th17, and Treg 
cells, respectively), in vitro after exposure of PBMC to TMCPM preparations, differing in the content 
of organic compounds. This work is a part of the APARIC project (Air Pollution versus Autoimmunity: 
Role of m ultiphase aqueous Inorganic Chem istry) aim ed to study  the influence of transition m etal 
com pounds as com ponents of air pollutants on the induction of autoim m une disorders [21].
2. Materials and Methods
2.1. TMCPM Preparation
Two different preparations of TMCPM (transition metal containing particulate matter) were used 
in the study: SRM 1648a—standard urban particulate m atter (purchased from the National Institute for 
Standards and Technology, Gaithersburg, MD, USA), designated as NIST, which is a conglomeration of 
fine and ultrafine particles (mean particle diam eter 5.85 pm), containing ca. 13% of carbon, including 
10.5% of organic carbon [22] and  LAP-SRM 1648a particulate m atter treated w ith in  120 m in w ith  
cold oxygen plasm a for the rem oval of organic com pounds from the reference material. Samples of 
LAP, w ith  rem oved organic content (containing less than  2% of organic carbon, and  less than  1% of 
nitrogen) w ere prepared in the D epartm ent of Inorganic Chemistry, Jagiellonian University, Krakow, 
Poland, as described previously [23]. Both preparations of TMCPM were weighted on a high precision 
microbalance and freshly suspended in RPMI 1640 m edium  (Corning, M anassas, VA, USA) in sterile 
conditions. Three final concentrations of TMCPM were experim entally established as non-cytotoxic 
for PBMC (1 pg/mL, 10 pg/mL, 100 pg/mL) and used in further experiments.
2.2. Cell Isolation
ACDA -treated blood from healthy donors w as purchased from the Regional Center of Blood 
D onation and  Blood Therapy in Krakow, Poland. Peripheral blood m ononuclear cells (PBMC) were 
isolated by standard Pancoll hum an (Panbiotech, Aidenbach, Germany) density gradient centrifugation, 
w ashed  and  resuspended  in  RPMI 1640 m edium  (Corning), containing 10% heat-inactivated fetal 
bovine serum  (EURx, Gdańsk, Poland). Monocytes w ere separated from PBMCs by counter-current 
centrifugal elutriation (JE-6B elutriation system equipped w ith a 5-mL Sanderson separation chamber;
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Beckmann-Coulter, Palo Alto, CA, USA), as described previously [24] . Cells were washed, resuspended 
in RPMI 1640 m edium  supplem ented w ith  2 m M  of L-glutam ine, 5% heat-inactivated fetal bovine 
serum (EURx), and 25 pg/mL gentamycin (Sigma, St. Louis, MO, USA) (complete medium) and kept in 
an ice bath until used. Purity of isolated monocytes was checked by flow cytom etry using anti-CD14 
antibody (BD Biosciences, Pharm ingen, San Diego, CA, USA) and did not drop below 90%. For some 
experim ents, population  of lym phocytes containing c.a. 80% of CD3-positive cells was isolated by 
counter-current centrifugal elutriation from PBMCs.
2.3. Cell Culture and Immunostaining for Intracellular Proteins
PBMC w ere cultured at the density  of 1 X 106/m L in ultra-low -attachm ent tubes (Corning) in 
com plete RPMI 1640 m edium , w ith  or w ithou t TMCPM (LAP and  NIST), a t three concentration 
1 pg/mL, 10 pg/mL, and 100 pg/mL. Cells were kept at 37 °C, 5% CO2 in a humidified atmosphere. As a 
positive control, cells were stim ulated w ith  50 ng/mL PMA (phorbol 12-myristate 13-acetate; Sigma) 
and  100 ng/m L of ionom ycin (Sigma). In some experim ents, in addition  to PBMC, the lym phocyte 
population was enriched in T cells (lymphocyte fractions from counter-current centrifugal elutriation) 
or such T cells w ere added  to m onocytes (10:1 ratio), exposed to TMCPM pre-treated or not w ith  
Polymyxin B (InvivoGen, San Diego, CA, USA) at the concentration 100 pg/mL were used. Cells were 
treated and cultured in a similar m anner as PBMC.
For intracellular detection of IFN-y, IL-4, IL-17A, and  FoxP3, to inhibit protein secretion, 2 pM 
Golgi Stop (containing m onensin; BD Biosciences) w as added  a t the beginning of culture, as was 
described previously [25]. After 5 h of culture (according to m anufacturer's instructions) the cells were 
harvested, washed once in ice-cold PBS (phosphate-buffered saline; Corning) w ith 5% heat-inactivated 
fetal bovine serum  (EURx) and  stained w ith  the cocktail of fluorescently conjugated m onoclonal 
antibodies, specific for hum an  CD4+, IFN-y (for Th1), IL-4 (for Th2), IL-17A (for Th17), and  FoxP3 
(for Treg), according to m anufacturer instructions (H um an Th1/Th2/Th17 and  H um an Th17/Treg 
Phenotyping Kits, BD Biosciences). Expression of intracellular proteins (IFN-y, IL-4, IL-17A, and 
FoxP3) w as m easured by 10-colour FACS Canto flow cytom eter (BD Biosciences, Im m unocytom etry 
Systems, San Jose, CA, USA) and analyzed using BD FACSDiva software version 8.0.1 (BD Biosciences). 
Typically, 10,000 events for CD4+ cells w ere recorded. Percent value of the cells positive for IFN-y, 
IL-4, IL-17A, and  FoxP3 w ere quantified as the frequency m easure of Th1, Th2, Th17, and  Treg 
cells, respectively.
2.4. Cytokine Detection by CBA
M onocytes at the density  of 3 X 105 were cultured at 37 °C in a hum idified 5% CO2 atm osphere 
in U ltra Low A ttachm ent tubes in com plete m edium  w ith  or w ithou t TMCPM (LAP and  NIST) at 
the concentration 100 pg/mL. M onocytes stim ulated w ith  400 U/mL of hum an recom binant IFN-y 
(Sigma) and  100 ng/mL of LPS (lipopolysaccharide) from Salmonella abortus equi (Sigma) were 
cultured simultaneously as a positive control. Supernatants from monocyte cultures were collected and 
concentration of TNF-a was determined by Cytokine bead array (CBA, H um an Inflammatory Cytokine 
Kit; BD Biosciences), according to m anufacturer's  instructions. Typically, data  from 3600 events for 
beads were acquired by a 10-colour FACSCanto flow cytometer (BD Biosciences) and analyzed using 
FCAP A rray v. 3.0 software (BD Biosciences).
2.5. Endotoxin Determination
Endotoxin (LPS) content in TMCPM (NIST and  LAP) preparations and  TMCPM treated w ith  
Polymyxin B (InvivoGen) (100 pg/mL; 15 min room temp) was measured by a quantitative ELISA-like 
heterogeneous enzymatic assay, using EndoLISA kit, according to m anufacturer's instructions (Hyglos 
GmbH, M unchen, Germany). TMCPM samples were resuspended in sterile PBS (Corning) and analyses 
w ere perform ed at a tem perature of 37 °C w ith  autom ated microplate reader Infinite 200 Pro (Tecan, 
M annedorf, Switzerland). Endotoxin from Escherichia coli B0:55 (Sigma) w as used as a standard.
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M easurem ents were repeated if the difference betw een sam ple duplicates exceeded 10%. Endotoxin 
concentrations w ere expressed as EU/mL, based on the EndoLISA standard  curve (four-param eter 
logistic non-linear regression model) required by the test.
2.6. Statistics
Statistical analysis w as perform ed by one-way ANOVA and t tests using PRISM G rsphPad 6.01 
software (G raphPad Software Inc., San Diego, CA, USA). Results w ere expressed as the m ean ± 
standard  error of m easurem ent (SEM). Statistical significance oS differences betw een the groups was 
considered at the following p values: * p < 0.01, ** p < 0.01, *** p < 0,001, **** p < 0.0001. Statistically 
significant differences in treated groups compared to controls were determ ined using the Dunnett test.
3. Results
3.1. TMCPM Reduces the Expression Level ofCD4 on the Surface of T Cells
Effect of TMCPM on the activity of hum an CD4+ T cell subsets w as investigated after five hours 
of healthy donor PBMCs exposure to NIST or LAP particles. The concentrations of NIST and  LAP 
used in the study  w ere established experim entally in a range from  1-100 pg/mL, as used at higher 
concentrations were cytotoxic (data not shown), confirming previous reports [22]. At first, we checked 
weather TMCPM may affect the proportion of CD4+ T cells and the expression of CD4 on their surface, 
as w as docum ented for PM A and ionom ycin [25- 27], po ten t activators of T cells. For this purpose, 
the population  of lym phocytes w as gated according to FSC/SSC param eters du ring  FACS analysis 
of PBMC and the expression of CD4 antigen (mean fluorescence intensity), as well as the percentage 
of CD4+ cells, w as analyzed. The results presented in Figure 1 show that the expression of the CD4 
antigen on the surface of T lym phocytes decreased after cells exposition to TMCPM, sim ilarly to the 
group of cells stimulated w ith PMA + ionomycin (Figure 1A). This effect was dose-dependent (data not 
shown), being m ost pronounced at the highest concentration (100 pg/mL) of NIST or LAP. However, 





PMA + Ionomycin NIST 100 |jg/ml
Figure 1. Cont.
LAP 100 Mg/ml










TM C PM  [pg/m l]
Figure 1. Effect of TMCPM (NIST or LAP) on the level of expression of CD4 on the surface of 
T cells and frequency of CD4+ T cells. PBMC were stimulated for 15 la with PMA + ionomycin or 
with NIST or LAP particles, stained with anti-CD4-PerCP-Cy5.5 conjugated mAb and analyzed lay 
flow cytometry (A) Histogram overlay shows fluorescence intensity (PerCP-Cy5.5) of CD4+ cells.
Grey histogram—fluorescence intensity of CD4+ cells in a control culture (without stimulation), 
black histogram—fluorescence intensity of CD4+ cells in the samples stimulated either with PMA 
(50 ng/mL) + ionomycin ((100 ngfmL) (left), 100 pg/mL LAP (middle) or 100 pgimL NIST (right). Note s 
decreased expression o( CD4 after stimulations of PBMC cells (decreased mean fluorescence intensity). 
Representative data fscm one ouf of thirteen experiments psrfosmed are shown. (B) M/lean ± SEM 
percentage va lu e/ of CD4 positive lymplfocytes in control cultures (without stimulation) and. in the 
groups stimulated either with PMA (50 ng/mL) -I- ionomycin 5100 ngtmL) or LAP or NI0T used aC three 
different concentrations (1 pg/mL, 10 |sg/mL, 100 pg/mL), calculate1 from dota obtained from thirteen 
indepandent experimenis (one-way ANOVA test).
3.2. TMCPM Activates CD4+ T Lymphocytes Depending on the Organic Compounds Content
PopuCation o/ CD4+ T cells is com posed of several subsefs, m ainly T h l, Th2, Thl7, and Treg. 
These populations were identified aiter Che exposure oi PBMC to TMCPM, according to the expressios 
of intracellular proteins, cdaracteristlc for each subset of IFN-y, IL-4, IL-17A, and FoxP3, respectively. 
The expocure of PBMC to NIST or LAP caused anincrease in the proportion o) cells positive for fFN-y 
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Figure 2. Flow cytometry analysis of intracellular proteins characteristic for specific Th subsets after 
exposition of PBMC to TMCPM. (A) Gating strategy for CD4+ T cell identification. Lymphocytes were 
defined according to FSC vs. SSC parameters from PBMC and then Th cells ■were gated according 
to CD4 expression. (B) Dot plots (IFN-y-FITC -vs. IL-4-APC; IL-17A-PE vs. FoxP3-APC) show CD4+ 
T cells positive for IFN-y, IL-4, IL-17A and FoxP3 in unstimulated control, cells stimulated -with 
PMA (50 ng/mL) + ionomycin (100 ng/mL) (positive control) or stimulated with NIST (100 pg/mL) 
or LAP (100 pg/mL). Shown are data from one representative experiment out of thirteen performed. 
The expression of intracellular proteins IFN-y, IL-4, IL-17A and FoxP3 was analyzed by flow cytometry 
after the cells were staining with the cocktail of fluorescently conjugated monoclonal antibodies, specific 
for IFN-y (Th1), IL-4 (Th2), IL-17A (Th17) and FoxP3 (Treg).
This effect was most pronounced for the hfghest concentration of NIST and LAP, when compared 
to the unstim ulated control group. Additionally, LAP used at the highest concentration did induce a 
considerable percentage of IL-17A-positive CD4+ T cells, however, it d id  no t reach such a high-level 
(Figure 2). This observation suggests that the effect of TMCPM was strongly dependent on the arganic 
fraction component in the particle preparation, as significsntly stronger immune response was detected 
w ith fhe use of NIST. At this time point, no SL-4-producing celts was detected after exposuee of PBMC to 
TMCPM (Figures 2 and 3A), while stimulation of PBMC w ith NIST or LAP induced a dose dependent 
decrease in the frequency of regulatory T cells, albeit w ith no statistical significance (data not shown).
Int. J. Environ. Res. Public Health 2020,17,1227 7 of 17
(A)
positive cells [%]
Sample IFN-y IL-4 IL-17A Fox-P3
control 0.56 ± 0.23 0.22 ± 0.04 0.27 ± 0.05 5.44 ± 1.00
PMA + 
Ionomycin
13.72 ± 2.04 0.65 ± 0.30 2.25 ± 0.89 6.75 ± 1.76
NIST 100 4.27 ± 1.19 0.18 ± 0.07 2.21 ± 0.26 6.36 ± 1.87
NIST 10 0.36 ± 0.13 0.08 ± 0.05 1.62 ± 0.38 5.52 ± 1.83
NIST 1 0.35 ± 0.19 0.08 ± 0.04 1.33 ± 0.45 3.86 ± 1.98
LAP 100 1.53 ± 1.16 0.28 ± 0.29 1.73 ± 0.36 6.24 ± 2.67
LAP 10 0.43 ± 0.08 0.09 ± 0.01 1.12 ± 0.40 6.40 ± 0.69
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Figure 3. Effect of PBMC exposition to TMCPM (NIST and LAP) on the ratio of Th1/Th2 and Treg/Th17 
T cells. PBMC were stimulated as described in Materials and methods and percentage of Th1, Th2, 
Th17, and Treg cells was quantified as the frequency of1 cells positive for IFN-y, IL-4, IL-17A, and 
FoxP3, respectively (A). The ratio of the frequency (%) of IFN-y positive to IL-4 positive CD4+ T cells 
(Th1/Th2) (B) and FoxP3 positive to IL-17A positive CD4+ T cells (Treg/Th17) (C) was calculated. Data 
are presented as mean ± SEM from twelve independent experiments. Differences between the groups 
were considered statistically significant at the following p values: * p < 0.1, ** p < 0.01, **** p < 0.0001.
3.3. TMCPM Exposure Is Skewing the Balance ofTh1/Th2 and Treg/Th17 Subsets
It is accepted that the ratio between Th1/Th2 and Treg/Th17 subsets correlates w ith the functional 
status of the immune system [28- 31]. In our study, we compared these ratios in the groups of cells with 
and w ithout exposure to TMCPM. Figure 3B. shows a significant increase in the Th1/Th2 ratio after cell 
exposure to h ighest concentration of NIST, being highly skew ed into Th1 pattern. The exposure of 
PBMC to LAP at highest concentration caused also an increase in Th1/Th2 ratio, albeit less pronounced. 
Moreover, the cells exposed to NIST or LAP showed markedly lower Treg/Th17 ratio in comparison to 
control, unexposed group. This was most pronounced for NIST, regardless of the particle concentration 
used (Figure 3C).
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Taken together, exposure of PBMC to TMCPM (NIST or LAP) caused an increase in the frequency 
of Th1 and Th17 cells, indicating changes in the polarization of the im m une response.
3.4. Monocytes Activation Is Required for TMCPM Induced Polarization ofTh1 and Th17 Immune Response
To answ er w hether T cells can directly respond to TMCPM, fractions containing lym phocytes 
w ere collected during  counter-current elutriation and such cell population, com posed m ainly of T 
lym phocytes (80 to 90% of CD3-positive cells) [31], w as incubated w ith  the selected concentrations 
of TMCPM. Thereafter intracellular expression of IFN-y, IL-4, IL-17A, and  FoxP3 w as detected in 
CD4+ cells by flow cytom etry and Th1/Th2 and Treg/Th17 ratios were calculated. The obtained data 
(Figure 4) show  that the expression of intracellular proteins, characteristic for each of CD4+ subset, 
did not change significantly after TMCPM treatment, documenting that TMCPM did not directly affect 
the com position of CD4+ T cells. This observation suggests that m onocytes play a crucial role in the 
induction of Th1 and Th17 im m une response after TMCPM treatment.
(A)
positive cells [%]
Sample IFN-y IL-4 IL-17A Fox-P3
control 0.54 ± 0.38 0.55 ± 0.50 0.82 ± 0.55 5.79 ± 1.60
PMA + lonomycin 3.96 ± 3.25 1.93 ± 0.79 2.65 ± 0.26 6.94 ± 2.76
NIST 100 0.65 ± 0.45 0.70 ± 0.42 1.27 ± 0.51 4.11 ± 1.71
LAP 100 0.44 ± 0.20 0.36 ± 0.06 0.79 ± 0.50 5.28 ± 1.12
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Figure 4. Effect of the exposition of T lymphocytes to TMCPM (NIST or LAP) on the Th1/Th2 and 
Treg/Thl7 ratios. T lymphocytes were stimulated with PMA (50 ng/mL) + ionomycin (100 ng/mL) 
(positive control) or with NIST or LAP (100 pg/mL). Percentage of Th1, Th2, Th17, and Treg cells 
was quantified as the frequency of cells positive for IFN-y, IL-4, IL-17A and FoxP3, respectively (A). 
The frequency ratio (%) of IFN-y positive to IL-4 positive CD4+ T cells (Th1/Th2) (15) and FoxP3 positive 
to IL-17A ppsitive CD4+ T cells (Treg/Th17) (C), was calculated. Data are presented as the mean ± SEM 
from three independent experiments performed.
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With this in mind, in the next set of experiments, purified monocytes were incubated w ith TMCPM 
in a similar manner, and production of pro-inflammatory cytokines TNF-a, IL-6, and IL-8, was detected 
in the culture supernatants by CBA. The obtained data (Figure 5) show that monocytes directly respond 
to TMCPM by production of cytokines, including TNF-a, IL-6, and IL-8.
TMCPM
[ng/ml]
Figure 5. Effect of TMCPM (LAP or NIST) on cytokine production by purified human monocytes. 
Monocytes -were stimulated with LAP or NIST at three different concentrations (1 pg/mL, 10 pg/mL, 
100 pg/mL). Concentrations of TNF-a (A), IL-6 (B ), and IL-8 (C) in culture supernatants were determmed 
by CBA. Data are presented as mean ± SEM. The figure shows the results from three independent 
experiments. Differences between the groups were considered statistically significant at the following 
p values: * p < 0.1, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
This effect was most significant for NIST particles, while, in the case of LAP, it was observed only 
at the highesC concentration, proving the im portance of the organic com pounds content irt TMCPM. 
The criticaC role of m onocytea in the induction of Th1 and Th17 im m une responre after TMCPM 
challenge w as further confirm ed by co-incubati on of puri fied m onocytes exposed to TMCPM w ith  
lym phocyte populatign enriched irt T cells. In this retting, polarization of CD4+ T celle inCo Th1 and 
Th17 by TMCPM exposure h rs  been restored (Figure 6).
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Figure 6. Flow cytometry analysis of Th1 and Th17 subsets after co-incubation of purified monocytes 
exposed to TMCPM with T lymphocytes. Dot plots (IFN-y-FITC vs. IL-17A-PE) show CD4+ T cells 
positive for IFN-y and IL-17A in unstimulated control, cells stimulated with PM A (50 n g/mL) + 
ionomycin (100 ng/mL) (positive control) and stimulated with NIST (100 mg/mL) or LAP (100 pg/mL). 
Shown are data from one representative experiment out of six performed. The expression of intracellular 
IFN-y and IL-17A was analyzed by flow cytometry after the cells were sfained with the c ocktail of 
fluorescently conjugated monoclonal antibodies, specific for IFN-y (Th1) and IL-17A (Th17).
3.5. Endoto xin Content Is Partially Responsible for Pro-Inflammatory Potency of TMCPM
The m ain o rganic candid ate re-pon sible eor activation of hum an monoc ytes for pro-rnflammatory 
activity of TMCPM is endotoxin (LPS). In rhir eegard, in the next step w e perform ed analysis of the 
endotoxin concentration in the euspensione of NIST and LAP particles. "The obtained data (Table 1) 
revealed that both preparations of TMCPM contain in their organie fraction also endotoxin 1.75 EU/mL 
and 0.40 EU/mL (at the highesI dose) for MST and LAP, respectively. However, pre-treatment of TMCPM 
w ith polymyxin B decreased endotoxin content to 0.10 EU/mL in NIST and to 0.00 EU/mL in LAP.





E. coli [ng/mL] LPS 0.5 5.50 0.00
TMCPM [pg/mL]
NIST 100 1.75 0.10
LAP 100 0.40 0.00
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TMCPM sam ples w ere resuspended  in  sterile PBS and  endotoxin (LPS) concentration in  NIST 
and  LAP preparations w as m easured by  a quantitative ELISA-like heterogeneous enzym atic assay. 
Endotoxin was neutralized by the pre-treatment of TMCPM for 15 min. w ith polymyxin B (100 pg/mL).
To further analyze the role of endotoxin content in  TMCPM on the activity of CD4+ T cells we 
exam ined how  the treatm ent of NIST and  LAP w ith  polym yxin B, a po ten t inhibitor of LPS activity, 
affects the Th1/Th2 and  Treg/Th17 balance. To this end w e analyzed the response of T lym phocytes, 
PBMC and T lymphocytes w ith monocytes added (10%) after stim ulation w ith TMCPM treated w ith 
polym yxin B. The obtained results are presented in Figures 7 and 8, respectively.
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Figure 7. Effect of the exposition of T lym phocytes (A,B), PBMC (C,D) and T lym phocytes with  
m onocytes added (E,F) to TMCPM (NIST or LAP) pre-treated with polymyxin B on the Th1/Th2 
ratio. Cells were stimulated as described in “Materials and Methods" with PMA (50 ng/mL) + 
ionomycin (100 ng/mL) (positive control) or with NIST or LAP (100 pg/mL) pre-treated with polymyxin 
B (100 pg/mL). (A,C,E) Percentage of Th1, Th2, Th17, and Treg cells w as quantified as the frequency 
of cells positive for IFN-y, IL-4, IL-17A, and FoxP3, respectively. (B,D,F) The frequency ratio (%) of 
IFN-y positive to IL-4 positive CD4+ T cells (Th1/Th2) was calculated. Data are presented as mean ± 
SEM from four independent experiments performed. Differences between the groups were considered 
statistically significant at the following p values: * p < 0.1, ** p < 0.01, *** p < 0.001.
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Figure 8. Effect of the exposition of T lym phocytes (A,B), PBMC (C,D) and T lym phocytes with  
monocytes added (E,F) to TMCPM (NIST or LAP) pre-treated with polymyxin 13 (100 pg/mL) on the 
Treg/Th17 ratio. Cells w e re stimulated as described in "Materials and Methods" with PMA (50 ng/mL) 
+ ionomycin (100 ng/mL) (positive control) and with NIST or LAP (100 pg/mL) pre-treated with  
Polymyxin 13 (100 pg/mL). /A,C,E) PercentageoL Th1, Th2, Thl7, and Treg cell!/ was quantified as the 
frequency of c ells pos itive for IFN-y, IL-4, IL-37A and FoxP3, respective ly. (B/D ,F) The ratio of the 
frequency (%) o /  FoxP3 positive to IL-17A p ositive CD4+ T cells (Treg/Th17) was calculated. The data 
are presented as mean ± SEM from four independent experiments performed. Differences between  
the groups were considered statistically significant at the following p values: * p < 0.1, ** p < 0.01, 
*** p < 0.001.
F
Int. J. Environ. Res. Public Health 2020,17,1227 13 of 17
These results clearly docum ent that polymyxin B treatment, although almost completely eliminated 
LPS activity in NIST (0.1 EU/mL) and com pletely in LAP preparation (0.0 EU/mL) does no t abrogate 
activation of Th1 and Th17 subsets in PBMC and in a co-culture of T cells w ith monocytes stimulated with 
such TMCPM. This data implicates, that in addition to relevance of organic compounds (including LPS), 
also the role of inorganic components of TMCPM in the activation of Th subsets. It is w orth mentioning 
tha t treatm ent of TMCPM by polym yxin B itself caused an increase in  IFN-y production by  T cells, 
observed especially in a positive control group (PMA+ionomycin), albeit w ith no statistical significance.
3.6. Both Organic and Inorganic Components of TMCPM Might Be Responsible for Activation of Monocytes 
and Propagation of Inflammatory Response
Next, to check how  m onocytes respond to stim ulation w ith  TMCPM treated w ith  polym yxin 
B w e analyzed T N F a production and  secretion by m onocytes after stim ulation w ith  NIST and  LAP, 
previously treated  or no t for LPS elim ination. The data  presented in Figure 9 clearly docum ent 
tha t treatm ent of TMCPM w ith  polym yxin B does no t com pletely abolish activation of m onocytes 
and  production/secretion of pro-inflam m atory TN Fa, suggesting the im portan t contribution in this 
phenom enon of inorganic components.
Figure 9. Effect of LPS inactivation in TMCPM (NIST and LAP) on TNFa production by purified human 
monocytes. Monocytes were stimulated for four hours with NIST or LAP (100 pg/mL) with or without 
pre-treatment with polymyxin B (100 pg/mL). Percentage "values of TNF-a positive monocytes (A) was 
analyzed by flow" cytometry after the cells w ire  stained with fluorescently conjugated monoclonal 
antibodies. Concentration of TNF-a (B) in culture supernatants were determined by CBA. Data 
are preeented as mean ± SEM. The figure show t tire; results from three independent experiments. 
Differences between tha groups were considered statistically signifkant: at tire following p values:
* p < 0.1, ** p < 0.01, *** p < 0.001.
4. Discussion
The grow ing list of evidence has docum ented the connection betw een concentration of fine 
particulate m atter in the air and  initiation, developm ent or exacerbation of allergies, inflam m atory 
and autoim mune disordeis [3,4]. In this report, we assessed the effect of two preparations of TMCPM, 
nam ely NIST and  LAP, differing in content of arganic com pounds, on the activity of h u m in  CD4+ 
T cell subsets. "This w as determ ined by the expreesion of intracellular proteins (IFN-y, IL-4, IL-17A, 
and Foxp3) characteristic )or specific CD1+ T lym phocyte subpopulotions (Th1, Th2, Th17, and Treg, 
respectively). In addition, tire ratios of Thl/Th2 and Treg/Thi7 cells after the treatm ent of PBMC with 
different concentrations of TMCPM were analyzed, ae the optimal balance oi Th1 to Th2 and T hl7  to 
Treg is a key elem ent responsible for m aintainin< h im eostasis in thp im m une system. The obtained 
data  suggest tha t exposition ol PBMC to TMC1M induces strong polarization of CD4+ T cells into
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Th1 and Th17 subsets. This was show n by increase in the proportion of IFN-y and IL-17A producing 
cells, w ith  concom itant decrease of the level of Treg cells. In a sim ilar study, Ma et al. also observed 
increased Th1 and Th17-like cytokine secretion after exposure of PBMC to particulate m atter 2.5 pm [32]. 
The m ain difference betw een M a's and our study  is the size and  com position of the PM. Contrary to 
our study, w here the standard  reference urban  air PM (SRM 1648a) w as used, in the cited w ork  the 
exact composition of the dust was not specified. Even though the final ou tput of PBMC exposition to 
PM was the same—an increase in Th1 and Th17 immune response. It seems, that although the size and 
com position of the PM sam ples used in different studies m ay vary  significantly, finally they lead to 
induction of the inflammatory reactions, albeit w ith different intensity. In keeping, it was documented, 
that the exposition of mice to ultrafine particles (less than  0.1 pm) elevates the frequency of Th1 cells 
in circulation and  reduces the level of Treg cells in the lungs [33]. Moreover, Z hang et al. described 
the increased ratio of Th17/Treg after the exposition of rats to smoke, suggesting its potential role in 
pathogenesis of smoke inhalation-induced acute lung injury [34], while the results from similar study 
in mice link Th17/Treg cells imbalance w ith pathogenesis of cigarette induced em physem a [35].
It is w orth  m entioning that, although generally sim ilar pattern  of Th1 and  Th17 cell activation 
have been observed for both  preparations of TMCPM used in our study, w e have noticed that NIST 
particles were m uch more potent in stim ulation of T cells, as significantly higher production of IFN-y 
and  IL-17A w as observed for the original NIST preparation  com pared to LAP. In keeping, recently 
M ikrut et al., using the sam e preparations of TMCPM show ed that the organic fraction from NIST 
was m ostly responsible for singlet oxygen photogeneration w hen com pared w ith  LAP particles [23]. 
In another study, G aw da et al. show ed that the urban particulate m atter SRM 1648a induced in vitro 
a dose-dependent production of pro-inflam m atory cytokines (TNF-a, IL-6, IL-12p40) by m urine 
macrophages [22]. Interestingly, under the sam e conditions, LAP particles were not able to stim ulate 
macrophages, however the cells prim ed w ith NIST or LAP showed a strong pro-inflammatory response 
upon LPS challenge. These observations docum ent im portant role of organic components content in a 
pro-inflam m atory action of TMCPM.
Of note, in our in vitro settings the described phenom enon w as observed only w hen a w hole 
population of PBMC had  been used or purified monocytes exposed to TMCPM had  been added  to T 
lymphocytes, as the exposition of T lymphocytes only to TMCPM had no effect on the CD4+ subsets 
polarization. This im plicates a crucial role of m onocytes in activation of CD4+ T cells by TMCPM. 
Indeed, in our experim ental settings monocytes stim ulated w ith TMCPM produced high am ounts of 
pro-inflam m atory cytokines, depending on the organic com pounds content in TMCPM preparations. 
Additionally, in M a's study, the increase in IFN-y, IL-10, IL-17, and IL-21 production after the exposure 
to particulate m atter 2.5 pm  required the presence of cells of m onocyte origin, as CD4+ and  CD8+ T 
cells treated w ith  PM2.5 in the absence of m acrophages d id  no t present higher IFN-y, IL-10, or IL-21 
expression [32]. Moreover, recently C astaneda et al. observed sim ilar pattern, w here activation of 
m ouse dendritic cells after PM treatm ent w as crucial for differentiation of naive CD4 T cells tow ards 
Th17 subset [36]. All together, these observations im plicate th a t m onocytes and  cells of their origin, 
e.g., m acrophages/dendritic cells are the prim ary  cells responding to PM. In respect to the organic 
compounds, TLRs are natural candidates for their recognition and initiation of inflammatory response 
of monocytes/macrophages to PM. Several other studies [37- 41] already suggested the involvement of 
endotoxin in promoting inflammation induced by PM. This was further supported by the effects of LPS 
inhibitors polymyxin B and LPS-binding protein on the reduction of pro-inflammatory activity of PM 
in vitro [42,43]. A lthough in our in vitro system  endotoxin concentrations in  TMCPM preparations 
correlated w ith  pro-inflam m atory cytokine secretion by m onocytes, this effect w as no t com pletely 
abrogated by polymyxin B treatment. These data suggest that endotoxin, although present in TMCPM 
compositions, m ay not be solely responsible for a robust cell activation. We cannot exclude other, yet 
unknow n, organic constituents w ithin TMCPM, especially w hen several other insoluble or microbial 
components have been implicated in the increased macrophage responsiveness to PM [38,43]. However, 
our LAP preparation contained a very low am ount of organic com pounds, limiting their contribution
Int. J. Environ. Res. Public Health 2020,17,1227 15 of 17
in this phenom enon. It seems that endotoxin is partially responsible for pro-inflammatory potency of 
TMCPM and its effect is further enhanced by inorganic components, including, e.g., transition metals, 
triggering the Fenton's reaction and generation of ROS (reactive oxygen intermediates) [44]. Actually, 
our unpublished data confirm this scenario in monocytes (Gałuszka et al, in preparation).
In sum m ary, our results indicate tha t treatm ent of hum an  PBMC w ith  TMCPM affects the 
balance of Th1/Th2 and  Treg/Th17 cells, prom oting activity of Th1 and  Th17 subsets. This effect is 
strongly dependent on monocytes and the organic compounds, including LPS in TMCPM composition. 
Polym yxin B treatm ent, however, does not com pletely abrogate activity of TMCPM to m onocytes, 
suggesting the role also for inorganic com ponents of air pollutants. The obtained data  suggest that 
polarization of Th cells tow ard Th1 and Th17 im m une response is a potential m echanism  prom oting 
developm ent and progression of allergy, and inflam m atory and  au toim m une disorders in  hum ans 
after exposure to TMCPM.
5. Conclusions
In conclusion, results of the present study indicated that in vitro exposure of PBMC to TMCPM 
stim ulates the expression of IFN-y and  IL-17A and decreases expression of FoxP3, prom oting 
pro-inflam m atory activity of the Th1 and Th17 subsets. This effect depends on m onocytes, organic 
(including LPS) and inorganic com pounds content in TMCPM. These findings support the hypothesis 
that TMCPM m ay contribute to the developm ent and exacerbation of allergies, and inflammatory and 
autoim m une disorders.
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